Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-21
    E.g., 2018-09-21

Articles

Pages

3471 items
12:16 PM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Oberland closes $800M healthcare fund

Oberland Capital Management LLC (New York, N.Y.) closed the Oberland Capital Healthcare II fund with $800 million. The royalty and credit opportunities fund plans to make investments of $20-$150 million in commercial or near-commercial stage...
6:06 AM, Sep 14, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Cigna launches $250M healthcare fund

Cigna Corp. (NYSE:CI) launched Cigna Ventures with a $250 million commitment to invest in start-up and growth-stage companies focused on insights and analytics; digital health and retail; and care delivery and management. Cigna said the fund,...
3:42 PM, Sep 13, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Vivo closes $635M life sciences fund

Vivo Capital said Sept. 11 it closed its oversubscribed Vivo Opportunity Fund with $635 million. The long-only public equity fund plans to invest in small to mid-cap companies through follow-ons, private placements, IPOs and block...
11:41 AM, Sep 07, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Fourth Element Capital raising first $175M fund

Fourth Element Capital (Minneapolis, Minn.), founded by Kathleen Tune and John Deedrick, is raising a $175 million debut fund to invest in companies within the medtech, device, tool, diagnostic and specialty pharma space. Deedrick told BioCentury...
10:57 AM, Sep 07, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Winter, Jackson, Ramakishnan, Balasubramaniam among co-founders of new U.K. fund Ahren

Ahren Innovation Capital LLP (Cambridge, U.K.) announced the first close of its Ahren LP fund with over $100 million from Aviva, Wittington Investments and undisclosed U.S. family offices. The fund declined to disclose the exact...
10:49 AM, Sep 07, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Seidenberg, Harper launch Westlake with $320M inaugural fund

Kleiner Perkins’ Beth Seidenberg launched a life science investment firm, dubbed Westlake Village BioPartners, with $320 million in committed capital for its first fund. Sean Harper, EVP and head of R&D at Amgen Inc. (NASDAQ:AMGN),...
12:35 PM, Aug 31, 2018  |  BC Week In Review | Financial News  |  Other Financial News

China GL Capital claims 5% stake in U.K.'s Oxford BioDynamics

Epigenetic biomarker company Oxford BioDynamics plc (LSE:OBD) partnered with GL Capital Group to address demand for healthcare and personalized medicine in China. The Greater China healthcare-focused firm will act as the U.K.-based biotech's lead mainland...
11:47 AM, Aug 31, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Harbin Gloria selling stake in biotech unit to new investors

Harbin Gloria Pharmaceuticals Co. Ltd. (SZSE:002437) said Aug. 17 it plans to sell a 51% stake in biotech subsidiary Guangzhou Gloria Biotechnology Co. Ltd. (Guangzhou, China) to 6 Dimensions Capital, Boyu Capital and two other...
10:39 AM, Aug 03, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Long Hill closes second fund at $265M

Long Hill Capital closed its second fund at $265 million. The firm intends to invest in Chinese technology-enabled healthcare and consumer companies that seek to improve health and quality of life (QOL). Long Hill has $400...
11:56 AM, Jul 13, 2018  |  BC Week In Review | Financial News  |  Other Financial News

Abingworth's BioVentures VII fund closes at $315M, exceeding target

Abingworth Management Ltd. closed its BioVentures VII fund at $315 million, exceeding the fund's $300 million target. Funds will be invested in the U.S. and Europe. Abingworth's therapeutic interests for BioVentures VII include next-generation cell therapies,...

Pages